Showing 1 - 9 results of 9 for search 'John S. Anderson', query time: 0.01s Refine Results
  1. 1
    The Cell Wall Teichuronic Acid Synthetase (TUAS) Is an Enzyme Complex Located in the Cytoplasmic Membrane of Micrococcus luteus

    The Cell Wall Teichuronic Acid Synthetase (TUAS) Is an Enzyme Complex Located in the Cytoplasmic Membrane of Micrococcus luteus by Lingyi Lynn Deng, Alice A. Alexander, Sijin Lei, John S. Anderson

    Published 2010-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Shigella and childhood stunting: Evidence, gaps, and future research directions.

    Shigella and childhood stunting: Evidence, gaps, and future research directions. by Karoun H Bagamian, John D Anderson Iv, Gabriela Blohm, Suzanne Scheele

    Published 2023-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    HIV chromatin is a preferred target for drugs that bind in the DNA minor groove.

    HIV chromatin is a preferred target for drugs that bind in the DNA minor groove. by Clayton K Collings, Donald W Little, Samuel J Schafer, John N Anderson

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Bactericidal Effects of 405 nm Light Exposure Demonstrated by Inactivation of Escherichia, Salmonella, Shigella, Listeria, and Mycobacterium Species in Liquid Suspensions and on Exposed Surfaces

    Bactericidal Effects of 405 nm Light Exposure Demonstrated by Inactivation of Escherichia, Salmonella, Shigella, Listeria, and Mycobacterium Species in Liquid Suspensions and on Ex... by Lynne E. Murdoch, Michelle Maclean, Endarko Endarko, Scott J. MacGregor, John G. Anderson

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Impact of primary care usual provider type and provider interdependence on outcomes for patients with diabetes: a cohort study

    Impact of primary care usual provider type and provider interdependence on outcomes for patients with diabetes: a cohort study by George L Jackson, Valerie A Smith, Sharron Docherty, Christine Everett, Jacob Christy, Heather Batchelder, Perri A Morgan, John B Anderson, Anthony Viera

    Published 2023-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity.

    Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity. by Adam S Coleman, Xiuli Yang, Manish Kumar, Xinyue Zhang, Kamoltip Promnares, Deborah Shroder, Melisha R Kenedy, John F Anderson, Darrin R Akins, Utpal Pal

    Published 2008-08-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Intermediate Clinical and Radiographic Outcomes of the Inbone II: for Patients with Five Years Minimum Follow-up

    Intermediate Clinical and Radiographic Outcomes of the Inbone II: for Patients with Five Years Minimum Follow-up by Parin Kothari MD, Alexander Phillips, Ramsey Potter, Drew Albert MD, MBA, Michelle A. Padley PhD, CRTM, John G. Anderson MD, Donald R. Bohay MD, FACS, John D. Maskill MD, Marshall A. Boose DO, Lindsey A. Behrend BS

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Treatment of Hallux Rigidus: Comparison of Hemiarthroplasty with Cartiva Implant, Allograft Interpositional Arthroplasty, and Arthrodesis

    Treatment of Hallux Rigidus: Comparison of Hemiarthroplasty with Cartiva Implant, Allograft Interpositional Arthroplasty, and Arthrodesis by Ryan Sanii MD, MPH, Kevin Phan MD, Drew Krumm MD, Daniel J. Patton MD, Tyler Madden MD, John G. Anderson MD, John D. Maskill MD, Donald R. Bohay MD, FACS, Michelle A. Padley PhD, Cameron G. Patthanacharoenphon MD

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.

    Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. by Gergely Tóth, Shyra J Gardai, Wagner Zago, Carlos W Bertoncini, Nunilo Cremades, Susan L Roy, Mitali A Tambe, Jean-Christophe Rochet, Celine Galvagnion, Gaia Skibinski, Steven Finkbeiner, Michael Bova, Karin Regnstrom, San-San Chiou, Jennifer Johnston, Kari Callaway, John P Anderson, Michael F Jobling, Alexander K Buell, Ted A Yednock, Tuomas P J Knowles, Michele Vendruscolo, John Christodoulou, Christopher M Dobson, Dale Schenk, Lisa McConlogue

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: